Sunday, July 14, 2024, 4:02 PM
**Donald Trump guilty on all counts in historic criminal trial. **Former President has been found guilty on all 34 counts in his New York criminal hush money trial. **The Republican candidate has denied wrongdoing and an attorney representing him said they would file appeal. **The first-ever criminal trial of an American president. **Case centered on allegations about falsifying business records. **Trial lasted for over six weeks presumptive presidential nominee. **Trump first former president to be convicted in US history. **The trial lasted for over six weeks against the presumptive Republican presidential nominee.
Home Top News Caretaker govt should not become ‘chair-taker’, says Bilawal

Caretaker govt should not become ‘chair-taker’, says Bilawal

PPP chairman expresses indifference to Zardari’s statement

by NWMNewsDesk
0 comment

PPP Chairman Bilawal Bhutto Zardari has advised that the caretaker government should not become “chair-taker”, reiterating that the interim setup cannot form policies.

“We have no objection to the caretaker, but they should not become ‘chair-taker’. If they become chairtaker then we will have an objection,” he told reporters while responding to a query in Badin.

He was responding to a query pertaining to the government’s measures to control the economy.

Bilawal replied that his party and the people have no issues if the measures were being introduced to bring the prices of electricity and petrol down.


“I think the economic crisis which has so many issues that it would not be resolved soon and if a solution is to be taken out then only elected representatives can bring out solutions to these problems,” Bilawal said.

When asked, Bilawal advised the reporter to question PPP co-chairman Asif Ali Zardari on his statement pertaining to the Election Commission of Pakistan to seek his understanding of the statement.


You may also like

In a recent breakthrough, researchers have found that the updated COVID-19 vaccine has demonstrated an impressive 95% efficacy rate against the emerging Delta variant, which has been causing widespread concern globally.


Latest Articles

© 2023 News World Media. All Rights Reserved.